Inocucor Corporation, a developer and producer of biological crop inputs for high-value produce and row crops, completed the final close of its Series B funding round at $15.9 million, with participation by existing investors Cycle Capital Management (Montreal), Desjardins Innovatech (Montreal), TPG ART (San Francisco),